Latest filing published 27 Jul 2026 for Usana Health Sciences INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Frederic J. Winssinger on record concern Usana Health Sciences Inc, in the capacity of board member. In total, 25 filings cover trades dated from 28 July 2021 to 23 July 2026.
No open-market purchase appears, only 3 sales worth €210k. Outside the open market, there are 22 option exercises.
On 27 July 2026 came the latest disclosure, an option exercise in Usana Health Sciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations